Industry Insights

  1. Key Updates To Implementing Regulation (EU) 520/2012 6/18/2025

    The evolving pharmaceutical landscape demands continuous regulatory adaptation to safeguard patient safety and ensure compliance, including making updates to reinforce a more centralized, transparent, and technologically aligned EU pharmacovigilance system.

  2. Top 9 AI Implementation Strategies For Pharmacovigilance 6/18/2025

    By following these nine strategies, organizations can implement AI in pharmacovigilance responsibly, ensuring systems that are aligned with the goal of improving patient safety and public health outcomes.

  3. BioMarin Generates Patient Experience Data With Early And Often Engagement 6/18/2025

    BioMarin Pharmaceutical's Ebony Dashiell-Aje, Ph.D., discusses how early and often patient engagement facilitates rich patient experience data generation.

  4. Dispelling Common Clinical Trial Oversight Myths 6/17/2025

    Many clinical trial oversight problems can be avoided or mitigated by sponsor understanding root causes and being a proactive collaborator with its partners.

  5. Innovations In Pediatric Depression Assessment 6/17/2025

    Discover the transformation of a complex assessment challenge into a competitive advantage. Our electronic CDRS-R doesn't just digitize the scale—it embeds clinical expertise, automates quality controls, and guides raters through every step to ensure consistent, reliable data.

  6. Psychedelic Clinical Trials: Methods And Mystique 6/17/2025

    The future of psychedelic medicine depends on applying strict scientific standards, using evidence-based approaches to manage the inherent challenges of studying these consciousness-altering compounds.

  7. 5 Ways To Make Your Investigator Meetings Fun And Functional 6/17/2025

    Discover five ways CROs and sponsors can better engage and communicate with site staff for better relationships and better trials.

  8. Validating Generative AI: A Framework For Reliability And Compliance 6/16/2025

    With structured CSA-driven validation and expert guidance, organizations can harness generative AI’s advantages safely and effectively, ensuring accuracy, compliance, and operational excellence.

  9. 2 Ways To Overcome The Challenge Of Developing Neurological Rare Diseases Drugs 6/16/2025

    GRIN Therapeutics CEO Bruce Leuchter, MD, explores how integrating new business models and technological advances will be crucial to developing new treatments for rare neurological disorders.

  10. From Legacy To Lifeline: Advancing Rare Disease Care 6/13/2025

    Learn about inspiring figures who lived with rare diseases, get a look at today’s rare disease research, and see how we support patients around the world in this eBook.